Sample-Global Compounding Pharmacies Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CAGR (2019-2024)<br />
<strong>Market</strong> Opportunity of <strong>Global</strong> <strong>Compounding</strong> <strong>Pharmacies</strong> <strong>Market</strong> - By Product Type<br />
Figure 34: <strong>Market</strong> Opportunity Chart of <strong>Global</strong> <strong>Compounding</strong> <strong>Pharmacies</strong> <strong>Market</strong> - By Product Type (Year-2024)<br />
6.00%<br />
5.00%<br />
Oral<br />
4.00%<br />
3.00%<br />
2.00%<br />
1.00%<br />
0.00%<br />
0 1000 2000 3000 4000 5000 6000 7000<br />
<strong>Market</strong> Size (USD Million) in Year 2024<br />
Topical<br />
Ophthalmic<br />
Injectables<br />
Others<br />
The segment of oral compounded formulations possessed the highest share of xx% in year 2018 due to its wide range of<br />
advantages such as ease of administration, ease of access, etc. Moreover, it is expected that this segment will also maintain its xx<br />
in the global market over the forecast period, reaching a share approximately xx% by the year 2024.<br />
(c) AZOTH Analytics<br />
20
Change language